|
2024
|
P/S
|
Dietary and nutritional supplements |
|
|
Invention
|
Autotaxin inhibitor compounds.
The present disclosure provides autotaxin (ATX) inhibitor compoun... |
|
2023
|
Invention
|
Eye drop composition comprising cftr modulator compound. The present invention provides an eye dr... |
|
|
Invention
|
Novel triheterocyclic compounds. Provided are triheterocyclic compounds, and more specifically tr... |
|
|
Invention
|
Substituted pyrazolo[1,5-a]pyrimidines as cftr modulators.
CFTR modulator compounds and composit... |
|
|
Invention
|
Prevention and/or treatment of cns disorders.
Adenosine receptor (e.g., A2A and/or A1 receptor) ... |
|
|
Invention
|
Novel quinazoline compound as kras inhibitor. The present invention relates to a novel quinazolin... |
|
|
Invention
|
Novel tetraheterocycle compound. The present invention relates to a novel tetraheterocycle compou... |
|
|
Invention
|
Antiviral use of heteroaryl derivative compound. The present invention relates to an antiviral us... |
|
|
P/S
|
Medical research; drug discovery services; development of pharmaceutical preparations and medicin... |
|
|
Invention
|
Novel acid secretion inhibitor and use thereof.
The present invention provides a novel compound ... |
|
|
Invention
|
Heteroaryl derivative compound and use thereof. The present invention relates to a fused heteroar... |
|
|
Invention
|
Novel bicyclic heteroaryl compound and use thereof. The present invention provides a novel compou... |
|
|
Invention
|
Novel crystalline form of isoxazole derivative or salt thereof. The present invention relates to ... |
|
|
Invention
|
Novel use of isoxazole derivative or salt thereof. The present invention relates to a use of an i... |
|
|
Invention
|
Methods of treating cancer using dual androgen receptor and pde5 inhibitor compounds. The present... |
|
|
Invention
|
Non-stop production process for improving freeze-drying survival, heat tolerance, shelf stability... |
|
|
Invention
|
Method for preparing 6-methoxypyridin-3-yl derivatives. The present invention relates to a method... |
|
|
Invention
|
Method for preparing 6-methoxypyridin-3-yl derivative. The present invention relates to a method ... |
|
|
Invention
|
Method for producing cftr activator compound and intermediate used therefor. The present inventio... |
|
|
Invention
|
Composition comprising cftr activator. The present invention relates to a composition comprising ... |
|
|
Invention
|
Novel salt of glp-1 receptor agonist compound, preparation method thereof and pharmaceutical comp... |
|
|
Invention
|
Glp-1 receptor agonist and use thereof. Disclosed are novel compounds of Chemical Formula 1, opti... |
|
|
P/S
|
Pharmaceutical preparations for immunity adjustment;
antibodies for veterinary purposes; chemico... |
|
|
P/S
|
Pharmaceutical preparations for immunity adjustment; Antibodies for veterinary purposes; Chemico-... |
|
|
Invention
|
Composition for preventing, alleviating, or treating intestinal disease. The present invention re... |
|
2022
|
Invention
|
Novel salt of 1-sulfonyl pyrrole derivative, preparation method thereof and pharmaceutical compos... |
|
|
Invention
|
Novel salt of 1-sulfonyl pyrrole derivative, method for preparing same, and pharmaceutical compos... |
|
|
Invention
|
Vaccine composition comprising inactivated pneumococcal mutant strain. pep27 pep27 gene deleted. |
|
|
Invention
|
Method for preparing isoxazole derivative, and intermediate thereof. The present invention relate... |
|
|
Invention
|
Method for preparing isoxazole derivative, and novel intermediate therefor. The present invention... |
|
|
Invention
|
Lactobacillus crispatus strain and composition for prevention or treatment of vaginitis comprisin... |
|
|
Invention
|
Uses of cftr modulator and/or pde4 inhibitor compounds. The present disclosure provides methods o... |
|
|
Invention
|
Immunocytokine containing il-21r mutein.
Provided herein is an immunocytokine comprising (i) an ... |
|
|
Invention
|
Immunocytokine containing il-21r mutein. Provided herein is an immunocytokine comprising (i) an a... |
|
|
Invention
|
Method of controlling blood sugar level and treatment of diabetes and related conditions.
Method... |
|
|
Invention
|
Method of controlling blood sugar level and treatment of diabetes and related conditions. A compo... |
|
|
Invention
|
Nitrogen oxide-donating pde-5 and/or pde-6 inhibitor compounds.
The present disclosure provides ... |
|
|
Invention
|
Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitor.
Disclosed herein are a... |
|
|
Invention
|
Pharmaceutical composition comprising gpr40 agonist and sglt-2 inhibitor. Disclosed herein are a ... |
|
|
Invention
|
Inhibitors of ano6 and their uses thereof. The present invention relates to a composition compris... |
|
|
Invention
|
Inhibitors of anoctamin 6 protein and uses thereof.
The present invention relates to a new compo... |
|
|
Invention
|
Inhibitors of anoctamin 6 protein and uses thereof. The present invention relates to a new compou... |
|
2021
|
Invention
|
Novel salt of phenyl propionic acid derivative, method for producing same, and pharmaceutical com... |
|
|
Invention
|
Substituted pyrazolo[1,5-a]pyrimidines as cftr modulators. The present disclosure provides CFTR m... |
|
|
Invention
|
Novel crystalline form of gpr40 agonist.
The present invention relates to a novel crystalline fo... |
|
|
Invention
|
Acid secretion inhibitor and use thereof. The present invention provides a novel compound represe... |
|
2020
|
Invention
|
Adenosine receptor antagonist compounds.
The present disclosure provides adenosine receptor (e.g... |
|
|
Invention
|
Glp-1 receptor agonist and use thereof.
The present invention provides novel compounds of chemic... |
|
2016
|
P/S
|
Vitamin preparations; nutritional supplements consisting of vitamins and minerals; pharmaceutical... |
|
1997
|
P/S
|
Vitamin preparations, medicines for peripheral nervous system, medicines for circulatory organs, ... |
